Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Luminex Corporation LMNX

Healthcare
Luminex Corp develops, manufactures, and sells proprietary biological testing technologies and products to testing laboratories. It primarily serves the life sciences industries by selling products used by laboratory professionals and clinical laboratories in performing diagnostics, drug research and discovery, and clinical tests on patients. Luminex's market segments mainly include Infectious... see more

Recent & Breaking News (NDAQ:LMNX)

Luminex Corporation Third Quarter Earnings Release Scheduled for October 30, 2017

PR Newswire October 9, 2017

Luminex Corporation To Present At Cantor Fitzgerald's Global Healthcare Conference

PR Newswire September 19, 2017

Luminex Corporation Declares Third Quarter Cash Dividend

PR Newswire September 12, 2017

Luminex Corporation and Sutter Health Collaborate to Improve Patient Care

PR Newswire August 29, 2017

Luminex Corporation Reports Second Quarter 2017 Financial Results

PR Newswire August 7, 2017

Luminex Corporation Receives FDA Clearance for ARIES C. difficile Assay

PR Newswire July 24, 2017

Luminex Corporation Second Quarter Earnings Release Scheduled for August 7, 2017

PR Newswire July 17, 2017

Luminex Corporation Receives CE-IVD Mark for ARIES® Norovirus Assay

PR Newswire Europe Non Regulatory June 28, 2017

Luminex Corporation's VERIGENE Gram-Positive and Gram-Negative Blood Culture Panels Receive Reimbursement Approval in Japan

PR Newswire Asia June 12, 2017

Luminex Corporation's VERIGENE Gram-Positive and Gram-Negative Blood Culture Panels Receive Reimbursement Approval in Japan

PR Newswire June 5, 2017

Luminex Corporation To Present At Jefferies 2017 Global Healthcare Conference

PR Newswire May 25, 2017

Luminex Corporation Declares Second Quarter Cash Dividend

PR Newswire May 24, 2017

Luminex Corporation Receives FDA Clearance for ARIES Bordetella Assay

PR Newswire May 3, 2017

Mid-Afternoon Market Update: Crude Oil Down 2.5%; Chegg Surges Higher

Benzinga.com  May 2, 2017

Luminex Corporation Reports Record First Quarter 2017 Financial Results; Raises 2017 Financial Guidance

PR Newswire May 1, 2017

Luminex Corporation To Present At The Deutsche Bank 42nd Annual Health Care Conference

PR Newswire April 26, 2017

Luminex Corporation To Present At Bank Of America Merrill Lynch 2017 Health Care Conference

PR Newswire April 20, 2017

Luminex Corporation First Quarter Earnings Release Scheduled for May 1, 2017

PR Newswire April 10, 2017

Luminex Corporation To Present At The Barclays Global Healthcare Conference

PR Newswire March 1, 2017

Luminex Corporation Announces Initiation of Cash Dividend

PR Newswire February 21, 2017